Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johnny Moons

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Interactive Cardiovascular and Thoracic Surgery|April 2, 2015
Thoracoscopic tunnel technique for anatomical lung resections: a 'fissure first, hilum last' approach with staplers in the fissureless patientHerbert Decaluwe, Youri Sokolow, Frederic Deryck, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 26, 2011
Minimally invasive oesophagectomy: a valuable alternative to open oesophagectomy for the treatment of early oesophageal and gastro-oesophageal junction carcinomaPhilippe Nafteux, Johnny Moons, Willy Coosemans, et al.
Acta Chirurgica Belgica|April 7, 2026
Recurrence Patterns after Primary Surgery and Neoadjuvant Chemoradiotherapy for Esophageal AdenocarcinomaAndreas Bouckaert, Johnny Moons, Toni Lerut, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 31, 2014
Can extracapsular lymph node involvement be a tool to fine-tune pN1 for adenocarcinoma of the oesophagus and gastro-oesophageal junction in the Union Internationale contre le Cancer (UICC) TNM 7th edition?†Philippe Nafteux, Toni Lerut, Gert De Hertogh, et al.
World Journal of Surgical Oncology|May 29, 2019
Analysis of patients scheduled for neoadjuvant therapy followed by surgery for esophageal cancer, who never made it to esophagectomyLieven Depypere, Melissa Thomas, Johnny Moons, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|November 19, 2020
Perioperative fluid management in esophagectomy for cancer and its relation to postoperative respiratory complicationsEleni Van Dessel, Johnny Moons, Philippe Nafteux, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 20, 2015
Major intraoperative complications during video-assisted thoracoscopic anatomical lung resections: an intention-to-treat analysisHerbert Decaluwe, René Horsleben Petersen, Henrik Hansen, et al.
The Annals of Thoracic Surgery|December 22, 2020
Importance of Lymph Node Response After Neoadjuvant Chemoradiotherapy for Esophageal AdenocarcinomaLieven Depypere, Gert De Hertogh, Johnny Moons, et al.
Annals of Surgery|February 24, 2006
Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomasAnn Driessen, Willy Landuyt, Sylvia Pastorekova, et al.
Journal of Thoracic Disease|July 13, 2018
ypT0N+: the unusual patient with pathological complete tumor response but with residual lymph node disease after neoadjuvant chemoradiation for esophageal cancer, what's up?Lieven Peter Depypere, Gil Vervloet, Toni Lerut, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Interactive Cardiovascular and Thoracic Surgery|April 2, 2015
Thoracoscopic tunnel technique for anatomical lung resections: a 'fissure first, hilum last' approach with staplers in the fissureless patientHerbert Decaluwe, Youri Sokolow, Frederic Deryck, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 26, 2011
Minimally invasive oesophagectomy: a valuable alternative to open oesophagectomy for the treatment of early oesophageal and gastro-oesophageal junction carcinomaPhilippe Nafteux, Johnny Moons, Willy Coosemans, et al.
Acta Chirurgica Belgica|April 7, 2026
Recurrence Patterns after Primary Surgery and Neoadjuvant Chemoradiotherapy for Esophageal AdenocarcinomaAndreas Bouckaert, Johnny Moons, Toni Lerut, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 31, 2014
Can extracapsular lymph node involvement be a tool to fine-tune pN1 for adenocarcinoma of the oesophagus and gastro-oesophageal junction in the Union Internationale contre le Cancer (UICC) TNM 7th edition?†Philippe Nafteux, Toni Lerut, Gert De Hertogh, et al.
World Journal of Surgical Oncology|May 29, 2019
Analysis of patients scheduled for neoadjuvant therapy followed by surgery for esophageal cancer, who never made it to esophagectomyLieven Depypere, Melissa Thomas, Johnny Moons, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|November 19, 2020
Perioperative fluid management in esophagectomy for cancer and its relation to postoperative respiratory complicationsEleni Van Dessel, Johnny Moons, Philippe Nafteux, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 20, 2015
Major intraoperative complications during video-assisted thoracoscopic anatomical lung resections: an intention-to-treat analysisHerbert Decaluwe, René Horsleben Petersen, Henrik Hansen, et al.
The Annals of Thoracic Surgery|December 22, 2020
Importance of Lymph Node Response After Neoadjuvant Chemoradiotherapy for Esophageal AdenocarcinomaLieven Depypere, Gert De Hertogh, Johnny Moons, et al.
Annals of Surgery|February 24, 2006
Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomasAnn Driessen, Willy Landuyt, Sylvia Pastorekova, et al.
Journal of Thoracic Disease|July 13, 2018
ypT0N+: the unusual patient with pathological complete tumor response but with residual lymph node disease after neoadjuvant chemoradiation for esophageal cancer, what's up?Lieven Peter Depypere, Gil Vervloet, Toni Lerut, et al.
Pageof 6